NCT02658981 Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) Status COMPLETED Phase PHASE1
NCT02655601 Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 Status COMPLETED Phase PHASE1/PHASE2
NCT02648633 Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma Status TERMINATED Phase PHASE1
NCT02644291 Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors Status COMPLETED Phase PHASE1
NCT02630030 Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT02629757 A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas Status UNKNOWN Phase PHASE3
NCT02617745 Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid Status COMPLETED Phase PHASE2
NCT02611024 Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02605746 Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis Status COMPLETED Phase EARLY_PHASE1
NCT02599090 Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma Status WITHDRAWN Phase PHASE2
NCT02590497 Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery Status WITHDRAWN Phase NA
NCT02585219 Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas Status UNKNOWN Phase N/A
NCT02575027 Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme Status COMPLETED Phase NA
NCT02573324 A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification Status COMPLETED Phase PHASE3
NCT02520635 Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients Status UNKNOWN Phase N/A
NCT02511405 A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) Status COMPLETED Phase PHASE3
NCT02490930 A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma Status COMPLETED Phase EARLY_PHASE1